Original Paper

Angiogenesis

, Volume 17, Issue 3, pp 519-527

First online:

VEGFA gene locus analysis across 80 human tumour types reveals gene amplification in several neoplastic entities

  • Mariacarla AndreozziAffiliated withMolecular Pathology Unit, Institute of Pathology, University Hospital of Basel
  • , Luca QuagliataAffiliated withMolecular Pathology Unit, Institute of Pathology, University Hospital of Basel
  • , Joel R. GsponerAffiliated withMolecular Pathology Unit, Institute of Pathology, University Hospital of Basel
  • , Christian RuizAffiliated withMolecular Pathology Unit, Institute of Pathology, University Hospital of Basel
  • , Vincent VuaroqueauxAffiliated withOncotest GmbH
  • , Serenella Eppenberger-CastoriAffiliated withMolecular Pathology Unit, Institute of Pathology, University Hospital of Basel
  • , Luigi TornilloAffiliated withMolecular Pathology Unit, Institute of Pathology, University Hospital of Basel
  • , Luigi M. TerraccianoAffiliated withMolecular Pathology Unit, Institute of Pathology, University Hospital of Basel Email author 

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access

Abstract

Background

Angiogenesis plays a pivotal role in neoplastic growth and metastasis formation. Vascular endothelial growth factor A (VEGFA) is a major player in physiological and tumour-induced angiogenesis and numerous human tumours have been show to overexpress VEGFA. Moreover increased VEGFA gene expression has been found frequently to correlate with tumour progression, recurrences and survival. Interestingly, several studies have demonstrated that gene amplification may result in protein overexpression and that amplification of the therapeutics’ target gene can serve as an excellent predictive marker (i.e. HER2 and trastuzumab). However the impact of VEGFA gene amplification has been only recently assessed for some cancer types such as osteosarcoma, colorectal, breast and liver cancer.

Aims

This study aimed to assess VEGFA gene amplification status using fluorescent in situ hybridization (FISH) in a large cohort of different tumour entities. Thus, we investigated the incidence of VEGFA amplification using a multi-tumour tissue microarray (TMA) containing 2,837 evaluable specimens from 80 different tumour entities and 31 normal tissue types. Moreover, we validated FISH analysis as reference method to evaluate VEGFA gene status by comparing it to comparative genomic hybridization (CGH).

Results

We observed that VEGFA locus amplification and/or polysomy represented a small but regularly detected population in several tumour entities while was not present in normal tissues. VEGFA gene alterations were predominantly observed in hepatocarcinomas, adenocarcinomas of the pancreas and intestine, large cell carcinoma of the lung and in endometrium serous carcinoma. Furthermore our data demonstrated that VEGFA detection by FISH provided highly comparable results to those generated by CGH.

Conclusion

Albeit with low percentage, VEGFA amplification is commonly observed across several tumour entities. Furthermore, our results demonstrated that FISH test could be used as a reliable diagnostic tool to evaluate VEGFA gene status in human specimens.

Keywords

VEGFA Gene amplification 6p12 FISH TMA